Industry: FDA’s proposed 510(k) changes more “benign” than feared

08.05.10
Publication: DOTmed News By: Brendon Nafziger

It looks like the medical device industry is breathing a collective sigh of relief after its initial review of the FDA’s proposed changes to its so-called fast-track 510(k) clearance rules. However some serious worries remain.

“[The] proposals are more benign than many had feared,” health care investment bank Leerink Swann’s analyst Rick Wise said in a mostly upbeat e-mail to investors Wednesday.

Click here to read the full article